Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.635 USD | +2.93% | +1.14% | -9.83% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.51% | 94.81M | |
-1.21% | 103B | |
+7.00% | 101B | |
+4.72% | 23.07B | |
-12.50% | 22.23B | |
-4.13% | 18.05B | |
-39.98% | 17.18B | |
-10.22% | 16.94B | |
+6.58% | 14.07B | |
+37.94% | 12.35B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- BioXcel Therapeutics' BXCL701 Granted FDA Fast-Track Designation to Treat Small Cell Neuroendocrine Prostrate Cancer